000 01176 a2200337 4500
005 20250514213100.0
264 0 _c20050222
008 200502s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.49.1.476.2005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aConceição, T
245 0 0 _aFirst isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJan 2005
300 _a476 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aKlebsiella Infections
_xmicrobiology
650 0 4 _aKlebsiella oxytoca
_xdrug effects
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPortugal
650 0 4 _abeta-Lactamases
_xgenetics
700 1 _aBrízio, A
700 1 _aDuarte, A
700 1 _aBarros, R
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 49
_gno. 1
_gp. 476
856 4 0 _uhttps://doi.org/10.1128/AAC.49.1.476.2005
_zAvailable from publisher's website
999 _c15297735
_d15297735